Healios K.K. (TYO:4593)
Japan · Delayed Price · Currency is JPY 286.00
+4.00 (1.42%)
Aug 27, 2026, 11:30 AM JST
Healios K.K. Income Statement
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 59 | 104 | 560 | 121 | 90 | 41 | |
Revenue Growth | -47.32% | -81.43% | 362.81% | 34.44% | 119.51% | 51.85% |
Cost of Revenue | 121 | 218 | 128 | 13 | - | - |
Gross Profit | -62 | -114 | 432 | 108 | 90 | 41 |
Selling, General & Admin | 1,433 | 1,256 | 1,365 | 1,116 | 1,378 | 1,649 |
Research & Development | 2,691 | 2,024 | 1,960 | 2,304 | 3,808 | 3,700 |
Other Operating Expenses | -32 | -69 | -54 | 1 | -10 | -2 |
Operating Expenses | 4,101 | 3,220 | 3,280 | 3,489 | 5,247 | 5,420 |
Operating Income | -4,163 | -3,334 | -2,848 | -3,381 | -5,157 | -5,379 |
Interest Expense | - | -59 | -87 | -146 | -418 | -583 |
Interest & Investment Income | 3,246 | 50 | 49 | 19 | 1 | - |
Earnings From Equity Investments | -2 | -2 | -2 | 2 | 3 | -3 |
Currency Exchange Gain (Loss) | -23 | -23 | 17 | 74 | -21 | 2 |
Other Non Operating Income (Expenses) | 905 | 905 | 105 | 298 | -29 | 101 |
EBT Excluding Unusual Items | -37 | -2,463 | -2,766 | -3,134 | -5,621 | -5,862 |
Gain (Loss) on Sale of Investments | -106 | -106 | 150 | - | - | -10 |
Asset Writedown | 442 | 442 | -1,446 | -492 | 292 | 1,411 |
Pretax Income | 299 | -2,127 | -4,062 | -3,626 | -5,329 | -4,461 |
Income Tax Expense | 85 | 102 | 165 | 187 | -159 | 450 |
Earnings From Continuing Operations | 214 | -2,229 | -4,227 | -3,813 | -5,170 | -4,911 |
Minority Interest in Earnings | -7 | 12 | -8 | -10 | 1 | 1 |
Net Income | 207 | -2,217 | -4,235 | -3,823 | -5,169 | -4,910 |
Net Income to Common | 207 | -2,217 | -4,235 | -3,823 | -5,169 | -4,910 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 123 | 108 | 88 | 68 | 57 | 53 |
Shares Outstanding (Diluted) | 131 | 116 | 88 | 68 | 57 | 57 |
Shares Change | 37.66% | 30.94% | 30.10% | 19.28% | -0.65% | 11.60% |
EPS (Basic) | 1.69 | -20.59 | -47.87 | -56.22 | -90.67 | -93.36 |
EPS (Diluted) | -5.03 | -26.60 | -47.87 | -56.22 | -90.67 | -99.52 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -4,385 | -3,333 | -1,832 | -2,847 | -4,808 | -5,382 |
Free Cash Flow Per Share | -33.48 | -28.77 | -20.71 | -41.87 | -84.34 | -93.79 |
Gross Margin | -105.09% | -109.61% | 77.14% | 89.26% | 100.00% | 100.00% |
Operating Margin | -7055.93% | -3205.77% | -508.57% | -2794.22% | -5730.00% | -13119.51% |
Profit Margin | 350.85% | -2131.73% | -756.25% | -3159.50% | -5743.33% | -11975.61% |
Free Cash Flow Margin | -7432.20% | -3204.81% | -327.14% | -2352.89% | -5342.22% | -13126.83% |
EBITDA | -3,884 | -3,059 | -2,551 | -3,157 | -4,771 | -5,117 |
D&A For EBITDA | 279 | 275 | 297 | 224 | 386 | 262 |
EBIT | -4,163 | -3,334 | -2,848 | -3,381 | -5,157 | -5,379 |